What adjustments should be made to the Lantus (insulin glargine) dose, carb ratio, and correction scale for an 84-year-old type 2 diabetes patient with elevated overnight blood glucose levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Adjustment for 84-Year-Old Type 2 Diabetes Patient

For this 84-year-old type 2 diabetes patient with persistent hyperglycemia (BG 239 and 233), the Lantus dose should be increased from 25 to 29 units, the carb ratio should remain at 1:15, and the correction scale should be increased to high. 1

Lantus Dose Adjustment

  • The current basal insulin dose of 25 units is inadequate as evidenced by consistently elevated blood glucose readings (239 and 233 mg/dL) 1
  • For patients with persistent hyperglycemia on basal insulin, the American Diabetes Association recommends increasing the dose by 2-4 units 1
  • Given the patient's weight (74 kg), the current dose of 25 units equals approximately 0.34 units/kg/day, which is within the typical range of 0.1-0.4 units/kg/day for type 2 diabetes patients 1
  • Increase Lantus dose to 29 units (increase of 4 units) to improve overnight glycemic control 1

Carbohydrate Ratio Considerations

  • The current carbohydrate ratio of 1:15 (1 unit of insulin for 15g of carbohydrates) is reasonable for an elderly patient 2
  • In older adults, maintaining the current carbohydrate ratio is appropriate when making adjustments to basal insulin to minimize complexity and reduce risk of hypoglycemia 2
  • For patients receiving enteral bolus feedings, approximately 1 unit of insulin per 10–15g carbohydrate is recommended, confirming the current ratio is within appropriate range 2

Correction Scale Adjustment

  • The patient is currently on a "medium" correction scale but has persistent hyperglycemia 1
  • Increase to a "high" correction scale to provide more aggressive correction of elevated blood glucose levels 1
  • This adjustment will help address the current hyperglycemia while the increased basal insulin dose takes effect 3

Monitoring and Further Adjustments

  • After implementing these changes, monitor fasting blood glucose daily 1
  • If fasting glucose remains >150 mg/dL for 3 consecutive days, consider further increasing Lantus by 2 units 1
  • If any hypoglycemia occurs (glucose <70 mg/dL), reduce Lantus dose by 2-4 units 1
  • Special consideration for this 84-year-old patient: avoid aggressive titration to reduce risk of hypoglycemia 2

Age-Specific Considerations

  • For older adults (>80 years), glycemic targets are often less stringent (fasting glucose 90-150 mg/dL) to minimize hypoglycemia risk 2
  • In older adults with diabetes, insulin simplification is preferred when possible, supporting the decision to adjust basal insulin while maintaining the current carbohydrate ratio 2
  • The American Diabetes Association recommends cautious insulin adjustments in older adults, with a focus on avoiding hypoglycemia 2

Pitfalls to Avoid

  • Avoid excessive dose increases (>10% at once) as this increases hypoglycemia risk, particularly important in elderly patients 1
  • Don't delay insulin adjustments when blood glucose levels are consistently elevated, as prolonged hyperglycemia increases risk of complications 2
  • Be cautious of overbasalization - if fasting glucose normalizes but overall glycemic control remains poor, consider adding or adjusting prandial insulin rather than further increasing basal insulin 1
  • For elderly patients, avoid complex insulin regimens that may lead to administration errors and increased hypoglycemia risk 2

References

Guideline

Adjusting Basal Insulin Dose for Optimal Glycemic Control

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.